Rockwell Medical, Inc. (NASDAQ: RMTI)

Rockwell Medical, Inc. is a healthcare company that develops manufactures commercializes and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The company focuses on hemodialysis concentrates that are used in dialysis machines to remove toxins and balance electrolytes in patients blood. It operates manufacturing facilities in Michigan Texas and Iowa and serves customers in the United States and internationally.

Revenue is generated primarily from the sale of liquid and dry acid and bicarbonate concentrates used in hemodialysis treatment. The company also offers ancillary products such as cleaning agents salts and other supplies to dialysis providers. Sales are made directly to dialysis clinics hospitals and distributors both domestically and abroad.

Rockwell Medical holds a leading position as a supplier of liquid bicarbonate concentrates and is among the largest providers of acid and dry bicarbonate concentrates in the United States. Its main competitors are Fresenius Medical Care NA and Nipro Medical Corporation. The company differentiates itself through a reputation for reliability high quality manufacturing under cGMP standards and strong customer service relationships.

The company serves 294 customers including all five of the leading dialysis providers in the United States such as Fresenius and DaVita. DaVita represented approximately 16 percent of net product sales in 2025. In addition the company supplies distributors that reach more than 30 foreign countries primarily in the Americas and the Pacific Rim.